Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 772 across all filing types
Latest filing 2025-06-19 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2025-06-19 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains details of a notice received from the Goods and Service Tax (GST) Authority regarding a demand notice for GST liabilities. The document is a regulatory announcement informing the exchanges and public about this legal notice and the company's intended response. It does not contain financial statements, audit results, or detailed management discussion. The document length is 3314 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-06-13 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (National Stock Exchange of India and Bombay Stock Exchange) disclosing information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It relates to a regulatory disclosure about a GST authority order dropping proceedings against the company. The document is short (3297 characters) and serves as a regulatory announcement rather than a detailed report or financial statement. It does not contain financial data or detailed analysis but is a compliance disclosure about a regulatory matter. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about an upcoming analyst/institutional investors meeting scheduled for June 17, 2025. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6) related to disclosure of events. The content is an intimation or announcement of a meeting rather than a detailed report or transcript. The document length is short (1778 characters), and it does not contain financial data, management discussion, or detailed presentation materials. Therefore, it fits best under the category of Investor Presentation (IP) or Regulatory Filings (RNS). However, since it is only an intimation of a meeting and not the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories. Confidence is high due to clear regulatory reference and document nature.
2025-06-12 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the receipt and subsequent dropping of a GST notice by the tax authority. The document includes details of the regulatory action and its impact, but it does not contain financial statements or detailed financial analysis. The document length is 3360 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. It is a regulatory compliance disclosure about a legal/tax matter, not a full audit report or annual/interim report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-11 English
Product launch
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a pharmaceutical product by Indoco Remedies Limited's subsidiary in the UK. It is addressed to stock exchanges pursuant to SEBI regulations, specifically Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document contains no financial statements, no detailed financial analysis, or comprehensive report content. It is a regulatory announcement informing the market about a significant business development (product launch). The document length is 4846 characters, which is relatively short and consistent with a press release or regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.